Sanofi BNP Paribas Primary New Issues : Stabilisation Notice


Date: 15th March 2018

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Sanofi

Post-stabilisation Period Announcement

NO STABILISATION CARRIED OUT

Further to the pre-stabilisation period announcement dated 14th March 2018 BNP Paribas, contact: Rupert Lewis telephone: 020 7595 8222 hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.


Issuer:  Sanofi
Guarantor (if any):  
Aggregate nominal amount: Eur 1 Billion 2yr FRN

Eur 500 Million 2 yr FXD

Eur 1.75 Billion 5 yr FXD

Eur 1.5 Billion 8 yr FXD

Eur 2 Billion 12 yr FXD

Eur 1.25 Billion 20 yr FXD
Description: 3mE+15 FRN Bonds due 2020

0 per cent Bonds due 2020

0.5 per cent Bonds due 2023

1 per cent Bonds due 2026

1.375 per cent Bonds due 2030

1.875 per cent Bonds due 2038
Stabilisation Manager(s): BNP Paribas/SG CIB/UniCredit/ Citi/HSBC/JPM/RBC CM/CACIB/ING/Santander 
Offer price: 2yr FRN 100.667

2yr FXD 100.184

5yr FXD 99.803

8yr FXD 99.618

12yr FXD 98.712

20yr FXD 99.439


This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

 

GlobeNewswire